CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction Prdm16 Deficiency Leads to Age-Dependent Cardiac Hypertrophy, Adverse Remodeling, Mitochondrial Dysfunction, and Heart Failure Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes Heart Failure With Preserved Ejection Fraction in the Young A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5) Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association

Original Research2014 Oct;2(5):457-65.

JOURNAL:JACC Heart Fail. Article Link

Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure

Felker GM, Ahmad T, Anstrom KJ et al. Keywords: biomarkers; clinical trial; heart failure

FULL TEXT PDF